• This record comes from PubMed

Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis

. 2023 Feb 23 ; 15 (5) : . [epub] 20230223

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic

Document type Journal Article

OBJECTIVES: To identify correlates of survival and perioperative outcomes of upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), and robotic (RRNU) radical nephroureterectomy (RNU). METHODS: We conducted a retrospective, multicenter study that included non-metastatic UTUC patients who underwent RNU between 1990-2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment and were adjusted by 1:1:1 propensity score matching (PSM). Survival outcomes per group were estimated for recurrence-free survival (RFS), bladder recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS). Perioperative outcomes: Intraoperative blood loss, hospital length of stay (LOS), and overall (OPC) and major postoperative complications (MPCs; defined as Clavien-Dindo > 3) were assessed between groups. RESULTS: Of the 2434 patients included, 756 remained after PSM with 252 in each group. The three groups had similar baseline clinicopathological characteristics. The median follow-up was 32 months. Kaplan-Meier and log-rank tests demonstrated similar RFS, CSS, and OS between groups. BRFS was found to be superior with ORNU. Using multivariable regression analyses, LRNU and RRNU were independently associated with worse BRFS (HR 1.66, 95% CI 1.22-2.28, p = 0.001 and HR 1.73, 95%CI 1.22-2.47, p = 0.002, respectively). LRNU and RRNU were associated with a significantly shorter LOS (beta -1.1, 95% CI -2.2-0.02, p = 0.047 and beta -6.1, 95% CI -7.2-5.0, p < 0.001, respectively) and fewer MPCs (OR 0.5, 95% CI 0.31-0.79, p = 0.003 and OR 0.27, 95% CI 0.16-0.46, p < 0.001, respectively). CONCLUSIONS: In this large international cohort, we demonstrated similar RFS, CSS, and OS among ORNU, LRNU, and RRNU. However, LRNU and RRNU were associated with significantly worse BRFS, but a shorter LOS and fewer MPCs.

Department of Urology 2nd Faculty of Medicine Charles University 150 06 Prague Czech Republic

Department of Urology Azienda Ospedaliera Universitaria Integrata of Verona University of Verona 37126 Verona Italy

Department of Urology Comprehensive Cancer Center Medical University of Vienna 1090 Vienna Austria

Department of Urology Erasmus MC Cancer Institute University Medical Center 3015 GD Rotterdam The Netherlands

Department of Urology Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Department of Urology Kindai University Faculty of Medicine Osaka 589 8511 Japan

Department of Urology Lions Gate Hospital North Vancouver BC V7L 2L7 Canada

Department of Urology Luzerner Kantonsspital 6004 Lucerne Switzerland

Department of Urology Mayo Clinic Rochester MN 55902 USA

Department of Urology Medical University of Silesia 40 752 Katowice Poland

Department of Urology Paracelsus Medical University Salzburg University Hospital Salzburg 5020 Salzburg Austria

Department of Urology Penn State Health Hershey PA 17033 USA

Department of Urology St Marianna University School of Medicine Kawasaki 214 8525 Japan

Department of Urology The James Buchanan Brady Urological Institute The Johns Hopkins University School of Medicine Baltimore MD 21231 USA

Department of Urology University Hospital Zurich 8091 Zurich Switzerland

Department of Urology University Medical Center Hamburg Eppendorf 20251 Hamburg Germany

Department of Urology University of Florence Careggi Hospital 50100 Florence Italy

Department of Urology University of Rennes 35000 Rennes France

Department of Urology University of Texas Southwestern Dallas TX 75390 USA

Department of Urology Uro Oncology Robot Assisted and Specialized Urologic Surgery University Hospital Cologne 50937 Cologne Germany

Department of Urology UROSUD La Croix Du Sud Hospital 31130 Quint Fonsegrives France

Department of Urology USC Norris Comprehensive Cancer Center University of Southern California Los Angeles CA 90033 USA

Department of Urology Weill Cornell Medical College New York NY 10065 USA

Division of Urology Department of Surgical Sciences San Giovanni Battista Hospital University of Studies of Torino 10124 Turin Italy

Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman 19328 Jordan

Institute for Urology and Reproductive Health Sechenov University 119991 Moscow Russia

Karl Landsteiner Institute of Urology and Andrology 1090 Vienna Austria

Urology Department Fundació Puigvert Autonomous University of Barcelona 08025 Barcelona Spain

Urology Department GRC n°5 Predictive Onco Uro AP HP Pitié Salpêtrière Hospital Sorbonne University 75013 Paris France

USC Institute of Urology Keck Medicine of USC University of Southern California Los Angeles CA 90007 USA

Vattikuti Urology Institute Henry Ford Hospital Detroit MI 48202 USA

See more in PubMed

Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021. CA Cancer J. Clin. 2021;71:7–33. doi: 10.3322/caac.21654. PubMed DOI

Margulis V., Shariat S.F., Matin S.F., Kamat A.M., Zigeuner R., Kikuchi E., Lotan Y., Weizer A., Raman J., Wood C.G., et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–1233. doi: 10.1002/cncr.24135. PubMed DOI

Rouprêt M., Babjuk M., Burger M., Capoun O., Cohen D., Compérat E.M., Cowan N.C., Dominguez-Escrig J.L., Gontero P., Mostafid A.H., et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur. Urol. 2021;79:62–79. doi: 10.1016/j.eururo.2020.05.042. PubMed DOI

Tinay I., Gelpi-Hammerschmidt F., Leow J.J., Allard C.B., Rodriguez D., Wang Y., Chung B.I., Chang S.L. Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: A 10-year population-based analysis. BJU Int. 2016;117:954–960. doi: 10.1111/bju.13375. PubMed DOI

Mourmouris P., Argun O.B., Tzelves L., Tuna M.B., Gourtzelidou M., Tziotis A., Kural A.R., Skolarikos A. Is robotic radical nephroureterectomy a safe alternative to open approach: The first prospective analysis. Arch. Ital. Urol. Androl. 2021;93:408–411. doi: 10.4081/aiua.2021.4.408. PubMed DOI

Simone G., Papalia R., Guaglianone S., Ferriero M., Leonardo C., Forastiere E., Gallucci M. Laparoscopic versus Open Nephroureterectomy: Perioperative and Oncologic Outcomes from a Randomised Prospective Study. Eur. Urol. 2009;56:520–526. doi: 10.1016/j.eururo.2009.06.013. PubMed DOI

Stewart G.D., Humphries K.J., Cutress M.L., Riddick A.C., McNeill S.A., Tolley D.A. Long-Term Comparative Outcomes of Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial-Cell Carcinoma After a Median Follow-Up of 13 Years. J. Endourol. 2011;25:1329–1335. doi: 10.1089/end.2011.0223. PubMed DOI

Lee H., Kim H.J., Lee S.E., Hong S.K., Byun S.-S. Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma. PLoS ONE. 2019;14:e0210401. doi: 10.1371/journal.pone.0210401. PubMed DOI PMC

Morselli S., Vitelli F.D., Verrini G., Sebastianelli A., Campi R., Liaci A., Spatafora P., Barzaghi P., Ferrari G., Gacci M., et al. Comparison of Tumor Seeding and Recurrence Rate After Laparoscopic vs. Open Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma. Front. Surg. 2021;8:652. doi: 10.3389/fsurg.2021.769527. PubMed DOI PMC

Zeuschner P., Vollmer S.G., Linxweiler J., Wagenpfeil G., Wagenpfeil S., Saar M., Siemer S., Stöckle M., Heinzelbecker J. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years. Surg. Oncol. 2021;38:101607. doi: 10.1016/j.suronc.2021.101607. PubMed DOI

Hanna N., Sun M., Trinh Q.-D., Hansen J., Bianchi M., Montorsi F., Shariat S.F., Graefen M., Perrotte P., Karakiewicz P.I. Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series. Eur. Urol. 2012;61:715–721. doi: 10.1016/j.eururo.2011.12.026. PubMed DOI

Pearce S.M., Pariser J.J., Patel S.G., Steinberg G.D., Shalhav A.L., Smith N.D. The effect of surgical approach on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy. Urol. Oncol. Semin. Orig. Investig. 2016;34:121.e15–121.e21. doi: 10.1016/j.urolonc.2015.09.008. PubMed DOI

Rodriguez J.F., Packiam V.T., Boysen W.R., Johnson S.C., Smith Z.L., Smith N.D., Shalhav A.L., Steinberg G.D. Utilization and Outcomes of Nephroureter-ectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. J. Endourol. 2017;31:661–665. doi: 10.1089/end.2017.0086. PubMed DOI

Mullen E., Ahmed K., Challacombe B. Systematic review of open versus laparoscopic versus robot-assisted nephroureterectomy. Rev. Urol. 2017;19:32–43. PubMed PMC

Peyronnet B., Seisen T., Dominguez-Escrig J.L., Bruins H.M., Yuan C.Y., Lam T., Maclennan S., N’dow J., Babjuk M., Comperat E., et al. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Asso-ciation of Urology Guidelines Systematic Review. Eur. Urol. Focus. 2019;5:205–223. doi: 10.1016/j.euf.2017.10.003. PubMed DOI

Veccia A., Antonelli A., Francavilla S., Simeone C., Guruli G., Zargar H., Perdoná S., Ferro M., Carrieri G., Hampton L.J., et al. Robotic versus other nephroureterectomy tech-niques: A systematic review and meta-analysis of over 87,000 cases. World J. Urol. 2020;38:845–852. doi: 10.1007/s00345-019-03020-1. PubMed DOI

Piszczek R., Nowak Ł., Krajewski W., Chorbińska J., Poletajew S., Moschini M., Kaliszewski K., Zdrojowy R. Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: An updated meta-analysis. World J. Surg. Oncol. 2021;19:129. doi: 10.1186/s12957-021-02236-z. PubMed DOI PMC

Lughezzani G., Jeldres C., Isbarn H., Sun M., Shariat S.F., Alasker A., Pharand D., Widmer H., Arjane P., Graefen M., et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients. Eur. J. Cancer. 2009;45:3291–3297. doi: 10.1016/j.ejca.2009.06.016. PubMed DOI

Favaretto R.L., Shariat S.F., Chade D.C., Godoy G., Adamy A., Kaag M., Bochner B.H., Coleman J., Dalbagni G. The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur. Urol. 2010;58:574–580. doi: 10.1016/j.eururo.2010.07.003. PubMed DOI PMC

Xylinas E., Rink M., Cha E., Clozel T., Lee R.K., Fajkovic H., Comploj E., Novara G., Margulis V., Raman J., et al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur. Urol. 2014;65:210–217. doi: 10.1016/j.eururo.2012.04.052. PubMed DOI

Roscigno M., Brausi M., Heidenreich A., Lotan Y., Margulis V., Shariat S.F., Van Poppel H., Zigeuner R. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer. Eur. Urol. 2011;60:776–783. doi: 10.1016/j.eururo.2011.07.009. PubMed DOI

Rink M., Fajkovic H., Cha E.K., Gupta A., Karakiewicz P.I., Chun F.K., Lotan Y., Shariat S.F. Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma. Eur. Urol. 2012;61:854–855. doi: 10.1016/j.eururo.2011.12.055. PubMed DOI

White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: Issues and guidance for practice. Stat. Med. 2011;30:377–399. doi: 10.1002/sim.4067. PubMed DOI

van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat. Methods Med. Res. 2007;16:219–242. doi: 10.1177/0962280206074463. PubMed DOI

Brookhart M.A., Schneeweiss S., Rothman K., Glynn R.J., Avorn J., Stürmer T. Variable Selection for Propensity Score Models. Am. J. Epidemiol. 2006;163:1149–1156. doi: 10.1093/aje/kwj149. PubMed DOI PMC

Clements M.B., Krupski T.L., Culp S.H. Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis. Ann. Surg. Oncol. 2018;25:2550–2562. doi: 10.1245/s10434-018-6557-8. PubMed DOI

Kim S.H., Song M.K., Kim J.K., Hong B., Kang S.H., Ku J.H., Jeong B.C., Seo H.K., On behalf of Urothelial Cancer-Advanced Research and Treatment (UCART) Study Group Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis. Cancer Res. Treat. 2019;51:963–972. PubMed PMC

Moschini M., Zamboni S., Afferi L., Pradere B., Abufaraj M., Soria F., D’Andrea D., Roupret M., De la Taille A., Simeone C., et al. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab. J. Urol. 2020;19:31–36. doi: 10.1080/2090598X.2020.1817720. PubMed DOI PMC

Xylinas E., Colin P., Audenet F., Phe V., Cormier L., Cussenot O., Houlgatte A., Karsenty G., Bruyère F., Polguer T., et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: Predictors and impact on subsequent oncological outcomes from a national multicenter study. World J. Urol. 2012;31:61–68. doi: 10.1007/s00345-012-0957-3. PubMed DOI

Xylinas E., Kluth L., Passoni N., Trinh Q.-D., Rieken M., Lee R.K., Fajkovic H., Novara G., Margulis V., Raman J.D., et al. Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool. Eur. Urol. 2013;65:650–658. doi: 10.1016/j.eururo.2013.09.003. PubMed DOI

Shigeta K., Kikuchi E., Hagiwara M., Ando T., Mizuno R., Miyajima A., Nakagawa K., Oya M. Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma. Surg. Oncol. 2017;26:73–79. doi: 10.1016/j.suronc.2017.01.003. PubMed DOI

Chen M.-K., Ye Y.-L., Zhou F.-J., Liu J.-Y., Lu K.-S., Han H., Liu Z.-W., Xu Z.-Z., Qin Z.-K. Clipping the extremity of ureter prior to nephroureterectomy is effective in preventing subsequent bladder recurrence after upper urinary tract urothelial carcinoma. Chin. Med. J. 2012;125:3821–3826. PubMed

Pizzighella M., Bruyère F., Peyronnet B., Graffeille V., Brichart N., Mori K., Verhoest G., Bensalah K., Moschini M., Xylinas E., et al. The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder Recurrence. J. Endourol. 2022;36:77–82. doi: 10.1089/end.2021.0303. PubMed DOI

Lai S., Guo R., Seery S., Wu P., Liu J., Zhang Y., Zhu S., Li X., Liu M., Wang J. Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: A systematic re-view and meta-analysis. Int. J. Surg. 2020;75:165–173. doi: 10.1016/j.ijsu.2020.01.016. PubMed DOI

Lai S.-C., Wu P.-J., Liu J.-Y., Seery S., Liu S.-J., Long X.-B., Liu M., Wang J.-Y. Oncological impact of different distal ureter managements during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma. World J. Clin. Cases. 2020;8:5104–5115. doi: 10.12998/wjcc.v8.i21.5104. PubMed DOI PMC

O’Brien T., Ray E., Singh R., Coker B., Beard R. Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial) Eur. Urol. 2011;60:703–710. doi: 10.1016/j.eururo.2011.05.064. PubMed DOI

Nazzani S., Bazinet A., Preisser F., Mazzone E., Tian Z., Mistretta F., Shariat S., Saad F., Zorn K.C., Montanari E., et al. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis. Int. J. Urol. 2019;26:487–492. doi: 10.1111/iju.13916. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...